Tilray is a global pioneer in the research, cultivation, production and distribution of medical cannabis and cannabinoids. Tilray was the first licensed producer of medical cannabis in the world to have its facility Good Manufacturing Practices (GMP) certified in accordance with European Medicine Agency (EMA) standards. The company currently serves tens of thousands of patients, physicians, pharmacies, governments, hospitals, and researchers in eight countries spanning four continents through its affiliated entities in Australia and New Zealand (Tilray Australia New Zealand Pty Ltd), Canada (Tilray Canada Ltd), Germany (Tilray Deutschland GmbH), and Portugal (Tilray Portugal Unipessoal Lda). Source
No articles found.
Headquartered in New York City, Take-Two Interactive Software, Inc. is a leading d...
Headquartered in New York City, Take-Two Intera...
Weâre an indie game publisher with a hard focus on approachable games that can b...
Weâre an indie game publisher with a hard foc...
Cavco is a leading designer and builder of systems-built structures including manu...
Cavco is a leading designer and builder of syst...
Therapix Biosciences Ltd. (NASDAQ: TRPX) is a specialty clinical-stage pharmaceuti...
Therapix Biosciences Ltd. (NASDAQ: TRPX) is a s...
CBD Life Sciences Inc.'s primary focus is on developing organic products such as C...
CBD Life Sciences Inc.'s primary focus is on de...
Mystic Holdings, Inc. is a holding company which, through its wholly-owned subsidi...
Mystic Holdings, Inc. is a holding company whic...
Scopus BioPharma develops small molecule therapeutics leveraging world-class exper...
Scopus BioPharma develops small molecule therap...
Join the National Investor Network and get the latest information with your interests in mind.